| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |


( Department of Pharmacology, George Washington University, School of Medicine, Washington, D.C.)
The incorporation of isotopic ethylene-C14-imino-s-triazine (TEM), Myleran, chlorambucil, and sulfur mustard into the DNA fraction of regenerating liver and of various mouse ascites lymphomas was measured. The in vivo incorporation of these alkylating agents was estimated to be of the order of 1 mole of drug per mole of DNA polymer. Results obtained by several different methods of isolation of DNA from in vivo-treated tissues failed to show marked differences in the amounts of isotope coupled to DNA. No correlation was apparent between the susceptibility of the various tumors and the relative amounts of isotope incorporated into tumor DNA fractions. Pretreatment of tumor with nonlabeled triethylene melamine (TEM) failed to alter incorporation patterns for labeled TEM. It was concluded that attack on the DNA itself does not necessarily represent the mechanism of action by which the alkylating agents exert their cytostatic or cytotoxic effects.
* Aided by grants from the Damon Runyon Memorial Fund for Cancer Research (DRIR-42), The American Cancer Society (T-14), and the Atomic Energy Commission (AT-(30-1)-1107).
Part of this material was presented in abstract at the VIIth International Cancer Congress, London, 1958.
Present address: National Institutes of Health, Bethesda, Md.
Received 10/31/60.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |